Jove
Visualize
Contact Us

Related Experiment Videos

Progressive Myoclonic Epilepsies.

Basim M. Uthman1, Andreas Reichl

  • 1University of Florida College of Medicine, Department of Neurology and Neurosciences, Malcom Randall Veterans Affairs Medical Center, Neurology Service (127), 1601 SW Archer Road, Gainesville, FL 32608, USA. Basim.Uthman@med.va.gov

Current Treatment Options in Neurology
|December 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biochemical engineering of 5hmdC-DNA using a Tet3 double-mutant.

Computational and structural biotechnology journal·2026
Same author

Kinetic Referencing Allows Identification of Epigenetic Cytosine Modifications by Single-Molecule Hybridization Kinetics and Superresolution DNA-PAINT Microscopy.

ACS nano·2023
Same author

Healthy volunteers in first-in-human oncology drug development for small molecules.

British journal of clinical pharmacology·2021
Same author

Intragenomic Decarboxylation of 5-Carboxy-2'-deoxycytidine.

Angewandte Chemie (International ed. in English)·2021
Same author

Nonclinical & clinical interface - extrapolation of nonclinical data to support Phase I clinical studies.

Regulatory toxicology and pharmacology : RTP·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Treating progressive myoclonus epilepsy (PME) is challenging, as myoclonus is often resistant to standard antiepileptic drugs (AEDs). Promising alternative treatments include zonisamide, piracetam, antioxidants, and lifestyle changes.

Area of Science:

  • Neurology
  • Epileptology

Background:

  • Progressive myoclonus epilepsy (PME) presents significant therapeutic challenges.
  • Generalized convulsive seizures are manageable with traditional antiepileptic drugs (AEDs), but myoclonus, a key debilitating symptom, is often refractory.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for managing progressive myoclonus epilepsy (PME).
  • To identify effective treatments for refractory myoclonus in PME patients.

Main Methods:

  • Literature review of pharmacological and non-pharmacological interventions for PME.
  • Analysis of clinical evidence for novel antiepileptic drugs (AEDs) and alternative therapies.

Main Results:

  • Zonisamide and piracetam show promise as add-on therapies for PME.

Related Experiment Videos

  • Antioxidants, 5-hydroxytryptophan (5-HTP), baclofen, diet, and physical therapy are potential options for intractable cases.
  • Occasional alcohol use has demonstrated some beneficial effects in specific instances.

    • Conclusions:

    • Comprehensive treatment strategies are essential for managing PME, addressing both seizures and myoclonus.
    • Exploring novel pharmacological agents and non-pharmacological approaches is crucial for improving patient outcomes in PME.
    • Individualized treatment plans, including lifestyle modifications, may offer cost-effective and safer alternatives.